Clinical trial
Efficacy and Safety of Peginesatide (AF37702) in the Treatment of Anemia in…
NCT00314795 · Takeda, Industry · Completed
Key facts
| NCT number | NCT00314795 |
|---|---|
| Title | Efficacy and Safety of Peginesatide (AF37702) in the Treatment of Anemia in Participants With Chronic Kidney Disease |
| Official title | An Open-Label Study to Investigate the Efficacy and Safety of AF37702 Injection in the Treatment of Anemia Caused by Antibody-Mediated Pure Red Cell Aplasia in Patients With Chronic Kidney Disease |
| Lead sponsor | Takeda, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Anemia, Chronic Kidney Disease, Chronic Renal Failure, Pure Red Cell Aplasia |
| Intervention type | Drug |
| Interventions | Peginesatide |
| Enrollment | 22 |
| Start date | Apr 6, 2006 |
| Primary completion | Oct 24, 2016 |
| Completion | Oct 31, 2016 |
| First posted | Apr 17, 2006 |
| Last update posted | Mar 14, 2019 |
| Countries | France, Germany, United Kingdom |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: